Literature DB >> 3943028

Incidence of heart disease and functional significance of changes in the electrocardiogram 10 years after radiotherapy for breast cancer.

L E Strender, J Lindahl, L E Larsson.   

Abstract

Late cardiac complications after radiotherapy for breast cancer was studied in 197 patients examined before, 6 months after, and 10 years after treatment. The 10-year follow-up was done by survey of the files of patients who had died and re-examination of patients who were alive and free of cancer. Among 95 patients who died, 3 died of cardiopulmonary diseases. Autopsy in 32 patients showed serious cardiac abnormalities in 3. Of 102 patients alive at follow-up, 3 reported heart symptoms. Sixty-nine patients participated in the re-examination. Electrocardiogram (ECG) abnormalities were found in 19% of these patients before treatment; in 45% at 6 months, essentially due to T-wave changes in patients who had received left-sided irradiation; and in 45% at 10 years, with fewer T-wave abnormalities but more ST depression and ectopic beats. Average working capacity was 83 W before, 81 W at 6 months, and 84 W at ten years. Average heart volume was 680 ml before, 689 ml at 6 months, and 718 ml (P less than 0.01) 10 years after treatment. In conclusion, there was a high incidence of ECG T-wave changes, but they were reversible, and the perimyocardial damage indicated was functionally insignificant. The incidence of serious cardiac complications was low.

Entities:  

Mesh:

Year:  1986        PMID: 3943028     DOI: 10.1002/1097-0142(19860301)57:5<929::aid-cncr2820570509>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Abreast in a boat--a race against breast cancer.

Authors:  D C McKenzie
Journal:  CMAJ       Date:  1998-08-25       Impact factor: 8.262

2.  Cardiovascular autonomic function in anthracycline-treated breast cancer patients.

Authors:  M Viniegra; M Marchetti; M Losso; A Navigante; S Litovska; A Senderowicz; L Borghi; J Lebron; D Pujato; H Marrero
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer.

Authors:  Kyle Wang; Kevin A Pearlstein; Nicholas D Patchett; Allison M Deal; Panayiotis Mavroidis; Brian C Jensen; Matthew B Lipner; Timothy M Zagar; Yue Wang; Carrie B Lee; Michael J Eblan; Julian G Rosenman; Mark A Socinski; Thomas E Stinchcombe; Lawrence B Marks
Journal:  Radiother Oncol       Date:  2017-10-16       Impact factor: 6.280

Review 4.  Radiation-induced heart disease: pathologic abnormalities and putative mechanisms.

Authors:  Neil K Taunk; Bruce G Haffty; John B Kostis; Sharad Goyal
Journal:  Front Oncol       Date:  2015-02-18       Impact factor: 6.244

5.  Dose to the cardio-pulmonary system and treatment-induced electrocardiogram abnormalities in locally advanced non-small cell lung cancer.

Authors:  Alexandra Hotca; Maria Thor; Joseph O Deasy; Andreas Rimner
Journal:  Clin Transl Radiat Oncol       Date:  2019-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.